Filed: 2/14/2023ACC: 0001012975-23-000091
📋 What this filing means
ARCH VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 8 equity positions with a total reported market value of $390.42M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
8
Positions
$390.42M
Total AUM (reported)
61.33M
Total Shares
Allocation by class
COM$390.42M100.0%
Portfolio Concentration
Top 3$292.19M74.8%
4–10$98.23M25.2%
Top 3 weight
74.8%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 61.33M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
61.33M
shares
% of voting shares100.0%
Investment Discretion (by position count)
Sole8
Shared0
Other0
Dominant voting typeNone · 100.0% of voting shares
Institutional Holdings8
Rows:
DENALI THERAPEUTICS, INC.
SOLEShares3.67M
TypeSH
Market value$102.03M
26.13%
Sole
0.00
Shared
0.00
None
3.67M
KARUNA THERAPEUTICS, INC.
SOLEShares512.87K
TypeSH
Market value$100.78M
25.81%
Sole
0.00
Shared
0.00
None
512.87K
EQRX, INC.
SOLEShares36.34M
TypeSH
Market value$89.39M
22.89%
Sole
0.00
Shared
0.00
None
36.34M
ERASCA, INC.
SOLEShares11.06M
TypeSH
Market value$47.65M
12.20%
Sole
0.00
Shared
0.00
None
11.06M
VERVE THERAPEUTICS, INC.
SOLEShares2.01M
TypeSH
Market value$38.87M
9.96%
Sole
0.00
Shared
0.00
None
2.01M
SINGULAR GENOMICS SYSTEMS, INC.
SOLEShares3.80M
TypeSH
Market value$7.64M
1.96%
Sole
0.00
Shared
0.00
None
3.80M
UNITY BIOTECHNOLOGY, INC.
SOLEShares1M
TypeSH
Market value$2.75M
0.71%
Sole
0.00
Shared
0.00
None
1M
METACRINE, INC.
SOLEShares2.94M
TypeSH
Market value$1.32M
0.34%
Sole
0.00
Shared
0.00
None
2.94M
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DENALI THERAPEUTICS, INC.SOLE | COM | 3.67M | SH | $102.03M 26.13% | 0.00 | 0.00 | 3.67M |
KARUNA THERAPEUTICS, INC.SOLE | COM | 512.87K | SH | $100.78M 25.81% | 0.00 | 0.00 | 512.87K |
EQRX, INC.SOLE | COM | 36.34M | SH | $89.39M 22.89% | 0.00 | 0.00 | 36.34M |
ERASCA, INC.SOLE | COM | 11.06M | SH | $47.65M 12.20% | 0.00 | 0.00 | 11.06M |
VERVE THERAPEUTICS, INC.SOLE | COM | 2.01M | SH | $38.87M 9.96% | 0.00 | 0.00 | 2.01M |
SINGULAR GENOMICS SYSTEMS, INC.SOLE | COM | 3.80M | SH | $7.64M 1.96% | 0.00 | 0.00 | 3.80M |
UNITY BIOTECHNOLOGY, INC.SOLE | COM | 1M | SH | $2.75M 0.71% | 0.00 | 0.00 | 1M |
METACRINE, INC.SOLE | COM | 2.94M | SH | $1.32M 0.34% | 0.00 | 0.00 | 2.94M |